← Back to Search

Retinoid

Tazarotene for Acne

Phase 3

Waitlist Available

Research Sponsored by Actavis Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up mean percent change from baseline to week 12

Awards & highlights

Summary

The purpose of this study is to compare the safety and therapeutic equivalence of a generic tazarotene foam 0.1% and the reference listed Fabior™ (tazarotene foam, 0.1%) in the treatment of acne vulgaris.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ mean percent change from baseline to week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~mean percent change from baseline to week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and mean percent change from baseline to week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percent Change in the Inflammatory (Papules and Pustules) Lesion Counts

Percent Change in the Non-inflammatory (Open and Closed Comedones) Lesion Counts

Side effects data

From 2014 Phase 3 trial • 893 Patients • NCT02267746

Headache

Nasopharyngitis

Dysmenorrhoea

Skin exfoliation

Diarrhoea

Influenza

Back pain

100%

80%

60%

40%

20%

Study treatment Arm

Test

Vehicle

Reference

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: TazaroteneExperimental Treatment1 Intervention

Tazarotene 0/1% foam (Actavis)

Group II: Fabior™(tazarotene)Active Control1 Intervention

Reference listed drug: Fabior™ 0.1% foam (Stiefel)

Group III: Vehicle foamPlacebo Group1 Intervention

Foam vehicle of the test product (Actavis)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Tazarotene

FDA approved

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Actavis Inc.Lead Sponsor

98 Previous Clinical Trials

24,354 Total Patients Enrolled

1 Trials studying Acne

1,001 Patients Enrolled for Acne

Keri WinklerStudy DirectorAkesis, LLC

~79 spots leftby Oct 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.